跳至主要内容
临床试验/NCT06996717
NCT06996717进行中(未招募)1 期

Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes

Ain Shams University1 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2025年1月1日最近更新:
干预措施
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
145
试验地点
1
主要终点
Increase the number of patients in the target Hb range

研究概览

简要总结

The study will assess role of rule based algorithm in anemia management in hemodialysis patients and its relation to patient's mortality

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients on hemodialysis for more than six months patients undergoing hemodialysis three times per week each session for 4 hours patients with urea reduction ratio>65% patients with transferrin saturation>20%

排除标准

  • patients with terminal illness or malignancy patients receiving hemodialysis from catheter or arteriovenous graft

研究组 & 干预措施

end stage renal disease patients

Experimental

management of different hemoglobin levels by erythropoietin stimulating agents according to expert opinion and according to algorithm

干预措施: ESA (Drug)

结局指标

主要结局

Increase the number of patients in the target Hb range

时间窗: 6 months

This study will achieve better dosing of erythropoietin stimulating agents using rule based algorithms to correct anemia and avoid unnecessary extra doses of erythropoietin stimulating agents with their side effects

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验